Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-A propensity score matched analysis.
Hematol Transfus Cell Ther
; 2024 May 25.
Article
in En
| MEDLINE
| ID: mdl-39095316
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Hematol Transfus Cell Ther
Year:
2024
Document type:
Article
Country of publication:
Brazil